Key facts
- This page summarizes John D. McKey Jr.'s Form 4 filing for iBio, Inc. (IBIO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 13 Dec 2021, 17:53.
John D. McKey Jr. - 09 Dec 2021 Form 4 Insider Report for iBio, Inc. (IBIO)
- Reporting relationship
- Director
- Issuer ticker
- IBIO
- Reported as of
- 09 Dec 2021
- Net transaction value
- $0
- Reporting owner signature
- /s/ John D. McKey, Jr.
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
John D. McKey Jr. filed Form 4 for iBio, Inc. (IBIO) on 13 Dec 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IBIO
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +109,000
- Change %
- Price
- $0.000000
- Shares after
- 109,000
- Date
- 09 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 109,000
- Exercise price
- $0.6938
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
John D. McKey Jr. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
These options vest pro rata on a monthly basis over 12 months.